Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx

被引:30
作者
Kuropkat, C
Venkatesan, TK
Caldarelli, DD
Panje, WR
Hutchinson, J
Preisler, HD
Coon, JS
Werner, JA
机构
[1] Univ Marburg, Dept Otolaryngol Head & Neck Surg, D-35037 Marburg, Germany
[2] Rush Presbyterian St Lukes Med Ctr, Dept Otolaryngol, Chicago, IL 60612 USA
[3] Rush Presbyterian St Lukes Med Ctr, Rush Canc Inst, Chicago, IL 60612 USA
[4] Rush Presbyterian St Lukes Med Ctr, Dept Pathol, Chicago, IL 60612 USA
关键词
oral cancer; proliferation; apoptosis; molecular regulators;
D O I
10.1016/S0385-8146(01)00129-8
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Abnormalities in genes regulating cell proliferation and death may affect disease outcome in squamous cell carcinoma (SCC) of the head and neck. Methods: Proliferative activity (Histone H3 in-situ-hybridization (HISH) labeling index (LI)) and the genes and/or gene products of Cyclin D-1, c-erbB-2, Bcl-2, p21, and p53, were investigated in 35 patients with SCC of the oral cavity and oropharynx, previously studied for p27 expression. Results: Overexpression or very low expression of Cyclin D-1 was associated with unfavorable disease outcome and shorter time-to-recurrence. High c-erbB-2 expression was significantly associated with shorter overall survival and was synergistic with low p27 expression. Bcl-2, HISH LI, p21 expression, and p53 mutation and protein analysis were not significantly predictive, but there were trends suggesting shorter disease-free/overall survival for patients with undetectable Bcl-2, high HISH, and mutant p53. Conclusions: Several cell proliferation and death regulators appeared to predict disease outcome. Limited evidence of cooperativeness among regulators was also seen. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 41 条
[1]  
AHOMADEGBE JC, 1995, ONCOGENE, V10, P1217
[2]   The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications [J].
Alaoui-Jamali, MA ;
Paterson, J ;
Al Moustafa, AE ;
Yen, L .
BIOCHEMISTRY AND CELL BIOLOGY, 1997, 75 (04) :315-325
[3]  
BORG A, 1990, CANCER RES, V50, P4332
[4]  
BOYLE JO, 1993, CANCER RES, V53, P4477
[5]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[6]   TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer [J].
Erber, R ;
Conradt, C ;
Homann, N ;
Enders, C ;
Finckh, M ;
Dietz, A ;
Weidauer, H ;
Bosch, FX .
ONCOGENE, 1998, 16 (13) :1671-1679
[7]  
FIELD JK, 1992, EUR J SURG ONCOL, V18, P168
[8]  
FRANK JL, 1994, CANCER-AM CANCER SOC, V73, P181, DOI 10.1002/1097-0142(19940101)73:1<181::AID-CNCR2820730131>3.0.CO
[9]  
2-3
[10]  
Friedman M, 1997, ANN OTO RHINOL LARYN, V106, P445